AIM
INDV icon

ARGA Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

ARGA Investment Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+5,920
New +$215K 0.01% 116
2026
Q1 		– Sell
-13,169
Closed -$473K – 122
2025
Q4 		$473K Hold
13,169
– – 0.01% 90
2025
Q3 		$318K Buy
+13,169
New +$276K 0.01% 100

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ARGA Investment Management's INDV Position: Q2 2026 in Review

ARGA Investment Management opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 5,920 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #116 among its holdings. This is a return to the name: ARGA Investment Management previously reported a position in INDV as recently as Q4 2025.

ARGA Investment Management first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $473K in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • ARGA Investment Management held 5,920 shares of Indivior Pharmaceuticals worth $243K as of Q2 2026.
  • Indivior Pharmaceuticals was a new ARGA Investment Management position in Q2 2026.
  • Indivior Pharmaceuticals made up 0.01% of ARGA Investment Management's portfolio in Q2 2026, its #116 holding.
  • ARGA Investment Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • ARGA Investment Management's Indivior Pharmaceuticals position peaked at $473K in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on ARGA Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.